Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes Project

N. Scott Litofsky, Elana Farace, Frederick Anderson, Christina A. Meyers, Wei Huang, Edward R. Laws, Adam I. Kaplan, Henry Brem, Mitchel S. Berger, Manfred Westphal

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

OBJECTIVE: To study the incidence of depression among patients undergoing surgery for high-grade glioma, document factors associated with the presence of depression, and examine the relationship between depression and patient outcome. METHODS: Physician and patient reports of depression were analyzed immediately postoperatively and again 3 and 6 months after surgery for high-grade glioma. Physician-reported depression was defined according to the Diagnostic and Statistical Manual of Mental Disorders, ed 4. Patient self-assessment of depression was based on responses to questions contained in two validated functional status surveys. Concordance of physician- and patient-reported depression was examined, along with the extent of use of pharmacological treatment for depression. Additional outcomes examined included quality of life, survival, patient satisfaction, and posttreatment complications. RESULTS: Data from 598 patients were analyzed. In the early postoperative period, physicians reported depression in 15% of patients, whereas 93% of patients reported symptoms consistent with depression. The incidence of patient self-reported depression remained similar at 3- and 6-month follow-up, whereas physician reported depression increased from 15% in the early postoperative period to 22% at both 3- and 6-month follow-up. Concordance between physician recognition of depression and treatment of depression was low initially (33%) and increased at 3 and 6 months (51 and 60%, respectively). As compared with patients who were not depressed, survival was shorter and complications were more common among depressed patients. CONCLUSION: Symptoms of depression were common immediately after surgery for glioma, and they increased throughout the 6-month period after surgery. These findings support the hypothesis that clinically important depression is a common complication in patients with high-grade glioma. Concordance between physician recognition of depression and self-reports of depression by patients was low. Concordance between physician recognition of depression and initiation of pharmacological anti-depressant therapy was fair in the early postoperative period and improved somewhat over the subsequent 6-month period; however, within the 6-month period after surgery for glioma, antidepressant therapy was provided for only 60% of patients in whom the physician recognized depressive symptoms and in only 15% of patients who self-reported symptoms of depression. Findings from this observational study suggest the need for a controlled trial that is designed to test the hypothesis that more attention to the identification of postoperative depression and aggressive treatment of depressive symptoms can improve the quality of life and survival of patients after surgery for high-grade glioma.

Original languageEnglish (US)
Pages (from-to)358-367
Number of pages10
JournalNeurosurgery
Volume54
Issue number2
DOIs
StatePublished - Feb 2004

Fingerprint

Glioma
Depression
Physicians
Postoperative Period
Survival
Quality of Life
Pharmacology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Litofsky, N. S., Farace, E., Anderson, F., Meyers, C. A., Huang, W., Laws, E. R., ... Westphal, M. (2004). Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes Project. Neurosurgery, 54(2), 358-367. https://doi.org/10.1227/01.NEU.0000103450.94724.A2
Litofsky, N. Scott ; Farace, Elana ; Anderson, Frederick ; Meyers, Christina A. ; Huang, Wei ; Laws, Edward R. ; Kaplan, Adam I. ; Brem, Henry ; Berger, Mitchel S. ; Westphal, Manfred. / Depression in Patients with High-grade Glioma : Results of the Glioma Outcomes Project. In: Neurosurgery. 2004 ; Vol. 54, No. 2. pp. 358-367.
@article{84c4f71cdbb94c60a25c82d43880ba4b,
title = "Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes Project",
abstract = "OBJECTIVE: To study the incidence of depression among patients undergoing surgery for high-grade glioma, document factors associated with the presence of depression, and examine the relationship between depression and patient outcome. METHODS: Physician and patient reports of depression were analyzed immediately postoperatively and again 3 and 6 months after surgery for high-grade glioma. Physician-reported depression was defined according to the Diagnostic and Statistical Manual of Mental Disorders, ed 4. Patient self-assessment of depression was based on responses to questions contained in two validated functional status surveys. Concordance of physician- and patient-reported depression was examined, along with the extent of use of pharmacological treatment for depression. Additional outcomes examined included quality of life, survival, patient satisfaction, and posttreatment complications. RESULTS: Data from 598 patients were analyzed. In the early postoperative period, physicians reported depression in 15{\%} of patients, whereas 93{\%} of patients reported symptoms consistent with depression. The incidence of patient self-reported depression remained similar at 3- and 6-month follow-up, whereas physician reported depression increased from 15{\%} in the early postoperative period to 22{\%} at both 3- and 6-month follow-up. Concordance between physician recognition of depression and treatment of depression was low initially (33{\%}) and increased at 3 and 6 months (51 and 60{\%}, respectively). As compared with patients who were not depressed, survival was shorter and complications were more common among depressed patients. CONCLUSION: Symptoms of depression were common immediately after surgery for glioma, and they increased throughout the 6-month period after surgery. These findings support the hypothesis that clinically important depression is a common complication in patients with high-grade glioma. Concordance between physician recognition of depression and self-reports of depression by patients was low. Concordance between physician recognition of depression and initiation of pharmacological anti-depressant therapy was fair in the early postoperative period and improved somewhat over the subsequent 6-month period; however, within the 6-month period after surgery for glioma, antidepressant therapy was provided for only 60{\%} of patients in whom the physician recognized depressive symptoms and in only 15{\%} of patients who self-reported symptoms of depression. Findings from this observational study suggest the need for a controlled trial that is designed to test the hypothesis that more attention to the identification of postoperative depression and aggressive treatment of depressive symptoms can improve the quality of life and survival of patients after surgery for high-grade glioma.",
author = "Litofsky, {N. Scott} and Elana Farace and Frederick Anderson and Meyers, {Christina A.} and Wei Huang and Laws, {Edward R.} and Kaplan, {Adam I.} and Henry Brem and Berger, {Mitchel S.} and Manfred Westphal",
year = "2004",
month = "2",
doi = "10.1227/01.NEU.0000103450.94724.A2",
language = "English (US)",
volume = "54",
pages = "358--367",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Litofsky, NS, Farace, E, Anderson, F, Meyers, CA, Huang, W, Laws, ER, Kaplan, AI, Brem, H, Berger, MS & Westphal, M 2004, 'Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes Project', Neurosurgery, vol. 54, no. 2, pp. 358-367. https://doi.org/10.1227/01.NEU.0000103450.94724.A2

Depression in Patients with High-grade Glioma : Results of the Glioma Outcomes Project. / Litofsky, N. Scott; Farace, Elana; Anderson, Frederick; Meyers, Christina A.; Huang, Wei; Laws, Edward R.; Kaplan, Adam I.; Brem, Henry; Berger, Mitchel S.; Westphal, Manfred.

In: Neurosurgery, Vol. 54, No. 2, 02.2004, p. 358-367.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Depression in Patients with High-grade Glioma

T2 - Results of the Glioma Outcomes Project

AU - Litofsky, N. Scott

AU - Farace, Elana

AU - Anderson, Frederick

AU - Meyers, Christina A.

AU - Huang, Wei

AU - Laws, Edward R.

AU - Kaplan, Adam I.

AU - Brem, Henry

AU - Berger, Mitchel S.

AU - Westphal, Manfred

PY - 2004/2

Y1 - 2004/2

N2 - OBJECTIVE: To study the incidence of depression among patients undergoing surgery for high-grade glioma, document factors associated with the presence of depression, and examine the relationship between depression and patient outcome. METHODS: Physician and patient reports of depression were analyzed immediately postoperatively and again 3 and 6 months after surgery for high-grade glioma. Physician-reported depression was defined according to the Diagnostic and Statistical Manual of Mental Disorders, ed 4. Patient self-assessment of depression was based on responses to questions contained in two validated functional status surveys. Concordance of physician- and patient-reported depression was examined, along with the extent of use of pharmacological treatment for depression. Additional outcomes examined included quality of life, survival, patient satisfaction, and posttreatment complications. RESULTS: Data from 598 patients were analyzed. In the early postoperative period, physicians reported depression in 15% of patients, whereas 93% of patients reported symptoms consistent with depression. The incidence of patient self-reported depression remained similar at 3- and 6-month follow-up, whereas physician reported depression increased from 15% in the early postoperative period to 22% at both 3- and 6-month follow-up. Concordance between physician recognition of depression and treatment of depression was low initially (33%) and increased at 3 and 6 months (51 and 60%, respectively). As compared with patients who were not depressed, survival was shorter and complications were more common among depressed patients. CONCLUSION: Symptoms of depression were common immediately after surgery for glioma, and they increased throughout the 6-month period after surgery. These findings support the hypothesis that clinically important depression is a common complication in patients with high-grade glioma. Concordance between physician recognition of depression and self-reports of depression by patients was low. Concordance between physician recognition of depression and initiation of pharmacological anti-depressant therapy was fair in the early postoperative period and improved somewhat over the subsequent 6-month period; however, within the 6-month period after surgery for glioma, antidepressant therapy was provided for only 60% of patients in whom the physician recognized depressive symptoms and in only 15% of patients who self-reported symptoms of depression. Findings from this observational study suggest the need for a controlled trial that is designed to test the hypothesis that more attention to the identification of postoperative depression and aggressive treatment of depressive symptoms can improve the quality of life and survival of patients after surgery for high-grade glioma.

AB - OBJECTIVE: To study the incidence of depression among patients undergoing surgery for high-grade glioma, document factors associated with the presence of depression, and examine the relationship between depression and patient outcome. METHODS: Physician and patient reports of depression were analyzed immediately postoperatively and again 3 and 6 months after surgery for high-grade glioma. Physician-reported depression was defined according to the Diagnostic and Statistical Manual of Mental Disorders, ed 4. Patient self-assessment of depression was based on responses to questions contained in two validated functional status surveys. Concordance of physician- and patient-reported depression was examined, along with the extent of use of pharmacological treatment for depression. Additional outcomes examined included quality of life, survival, patient satisfaction, and posttreatment complications. RESULTS: Data from 598 patients were analyzed. In the early postoperative period, physicians reported depression in 15% of patients, whereas 93% of patients reported symptoms consistent with depression. The incidence of patient self-reported depression remained similar at 3- and 6-month follow-up, whereas physician reported depression increased from 15% in the early postoperative period to 22% at both 3- and 6-month follow-up. Concordance between physician recognition of depression and treatment of depression was low initially (33%) and increased at 3 and 6 months (51 and 60%, respectively). As compared with patients who were not depressed, survival was shorter and complications were more common among depressed patients. CONCLUSION: Symptoms of depression were common immediately after surgery for glioma, and they increased throughout the 6-month period after surgery. These findings support the hypothesis that clinically important depression is a common complication in patients with high-grade glioma. Concordance between physician recognition of depression and self-reports of depression by patients was low. Concordance between physician recognition of depression and initiation of pharmacological anti-depressant therapy was fair in the early postoperative period and improved somewhat over the subsequent 6-month period; however, within the 6-month period after surgery for glioma, antidepressant therapy was provided for only 60% of patients in whom the physician recognized depressive symptoms and in only 15% of patients who self-reported symptoms of depression. Findings from this observational study suggest the need for a controlled trial that is designed to test the hypothesis that more attention to the identification of postoperative depression and aggressive treatment of depressive symptoms can improve the quality of life and survival of patients after surgery for high-grade glioma.

UR - http://www.scopus.com/inward/record.url?scp=10744225081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744225081&partnerID=8YFLogxK

U2 - 10.1227/01.NEU.0000103450.94724.A2

DO - 10.1227/01.NEU.0000103450.94724.A2

M3 - Article

C2 - 14744282

AN - SCOPUS:10744225081

VL - 54

SP - 358

EP - 367

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 2

ER -